Cargando…
A Case of Nivolumab-Induced Myositis
Nivolumab (Opdivo) is a monoclonal antibody classified as an immune modulator. A case is presented of nivolumab-induced myositis, an unlisted side effect.
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153342/ https://www.ncbi.nlm.nih.gov/pubmed/27864576 http://dx.doi.org/10.1634/theoncologist.2016-0170 |
_version_ | 1782474674247041024 |
---|---|
author | Fox, Eric Dabrow, Michael Ochsner, Greg |
author_facet | Fox, Eric Dabrow, Michael Ochsner, Greg |
author_sort | Fox, Eric |
collection | PubMed |
description | Nivolumab (Opdivo) is a monoclonal antibody classified as an immune modulator. A case is presented of nivolumab-induced myositis, an unlisted side effect. |
format | Online Article Text |
id | pubmed-5153342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | AlphaMed Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-51533422016-12-16 A Case of Nivolumab-Induced Myositis Fox, Eric Dabrow, Michael Ochsner, Greg Oncologist Letters to the Editor Nivolumab (Opdivo) is a monoclonal antibody classified as an immune modulator. A case is presented of nivolumab-induced myositis, an unlisted side effect. AlphaMed Press 2016-12 2016-11-18 /pmc/articles/PMC5153342/ /pubmed/27864576 http://dx.doi.org/10.1634/theoncologist.2016-0170 Text en ©AlphaMed Press |
spellingShingle | Letters to the Editor Fox, Eric Dabrow, Michael Ochsner, Greg A Case of Nivolumab-Induced Myositis |
title | A Case of Nivolumab-Induced Myositis |
title_full | A Case of Nivolumab-Induced Myositis |
title_fullStr | A Case of Nivolumab-Induced Myositis |
title_full_unstemmed | A Case of Nivolumab-Induced Myositis |
title_short | A Case of Nivolumab-Induced Myositis |
title_sort | case of nivolumab-induced myositis |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153342/ https://www.ncbi.nlm.nih.gov/pubmed/27864576 http://dx.doi.org/10.1634/theoncologist.2016-0170 |
work_keys_str_mv | AT foxeric acaseofnivolumabinducedmyositis AT dabrowmichael acaseofnivolumabinducedmyositis AT ochsnergreg acaseofnivolumabinducedmyositis AT foxeric caseofnivolumabinducedmyositis AT dabrowmichael caseofnivolumabinducedmyositis AT ochsnergreg caseofnivolumabinducedmyositis |